Search Results - "de Maturana, Ignacio Lopez"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2
  3. 3

    Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patients by Bleda, Silvia, De Haro, Joaquin, Varela, Cesar, Esparza, Leticia, De Maturana, Ignacio Lopez, Acin, Francisco

    Published in Growth factors (Chur, Switzerland) (01-10-2012)
    “…Objective. To determine the potential genotype vascular endothelial growth factor (VEGF) gene differences in diabetic patients with peripheral arterial disease…”
    Get full text
    Journal Article
  4. 4

    Anti-endothelial cell antibodies are associated with peripheral arterial disease and markers of endothelial dysfunction and inflammation by Varela, Cesar, de Haro, Joaquin, Bleda, Silvia, Esparza, Leticia, de Maturana, Ignacio Lopez, Acin, Francisco

    “…Our aim is to describe the effect of circulating anti-endothelial cell antibodies on the endothelial dysfunction, inflammation and early structural changes of…”
    Get full text
    Journal Article
  5. 5

    Inflammatory Burden Predicts Long-Term Outcomes in Endovascular Therapy in Peripheral Arterial Disease by Bleda, Silvia, De Haro, Joaquin, Acin, Francisco, Varela, Cesar, Esparza, Leticia, López de Maturana, Ignacio

    Published in Annals of vascular surgery (01-05-2013)
    “…Background Peripheral arterial disease (PAD) is a systemic inflammatory disorder that affects the entire vascular system. Endovascular therapy (EVT) is the…”
    Get full text
    Journal Article
  6. 6

    Effect of Simvastatin Treatment on “In Vitro” NLRP1 Inflammasome Expression in Peripheral Arterial Disease by Bleda, Silvia, de Haro, Joaquin, Lopez de Maturana, Ignacio, Varela, Cesar, Ferruelo, Antonio, Acin, Francisco

    Published in Annals of vascular surgery (01-10-2016)
    “…Background Inflammatory stress stimuli in the plasma of patients with peripheral artery disease (PAD) are able to trigger the expression of NLRP1 inflammasome…”
    Get full text
    Journal Article
  7. 7
  8. 8